Literature DB >> 27517079

Total Ankylosis of the Upper Left Limb: A Case of Progressive Osseous Heteroplasia.

Ali Birjandinejad1, Mohammad-Hossein Taraz-Jamshidi1, Sayyed Hadi Sayyed Hosseinian1.   

Abstract

Progressive osseous heteroplasia is a rare inherited disease that begins with skin ossification and proceeds into the deeper connective tissues. The disease should be distinguished from other genetic disorders of heterotopic ossification including fibrodysplasia ossificans progressiva (FOP) and Albright hereditary osteodystrophy (AHO). We report a case of progressive osseous heteroplasia in a twenty four years old male with a complaint of ankylosis of the entire upper left limb and digital cutaneous lesions and sparing of the other limbs and the axial skeleton. Absence of great toe malformation, presence of cutaneous ossification, dermal bone spicules extruding in fingers, and involvement of just left upper limb were unique findings in contrast with FOP diagnosis in this case. There is no effective treatment or prevention for POH. Awareness of diagnostic features is necessary in early diagnosis of POH.

Entities:  

Keywords:  Congenital abnormalities; Heterotopic ossification; Progressive osseous heteroplasia

Year:  2016        PMID: 27517079      PMCID: PMC4969380     

Source DB:  PubMed          Journal:  Arch Bone Jt Surg        ISSN: 2345-461X


  18 in total

1.  Progressive osseous heteroplasia: a rare case of late onset.

Authors:  R Seror; C Job-Deslandre; A Kahan
Journal:  Rheumatology (Oxford)       Date:  2007-01-10       Impact factor: 7.580

2.  Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.

Authors:  Maria H Lin; Nawaporn Numbenjapon; Emily L Germain-Lee; Pisit Pitukcheewanont
Journal:  J Pediatr Endocrinol Metab       Date:  2015-07       Impact factor: 1.634

Review 3.  Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases.

Authors:  F S Kaplan; R Craver; G D MacEwen; F H Gannon; G Finkel; G Hahn; J Tabas; R J Gardner; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1994-03       Impact factor: 5.284

4.  Progressive osseous heteroplasia.

Authors:  E S Miller; N B Esterly; J A Fairley
Journal:  Arch Dermatol       Date:  1996-07

5.  GNAS-associated disorders of cutaneous ossification: two different clinical presentations.

Authors:  R J Schimmel; S G M A Pasmans; M Xu; S A E Stadhouders-Keet; E M Shore; F S Kaplan; N M Wulffraat
Journal:  Bone       Date:  2009-11-10       Impact factor: 4.398

6.  Progressive osseous heteroplasia resulting from a new mutation in the GNAS1 gene.

Authors:  I Chan; T Hamada; C Hardman; J A McGrath; F J Child
Journal:  Clin Exp Dermatol       Date:  2004-01       Impact factor: 3.470

7.  A case of progressive osseous heteroplasia: a first case in Japan.

Authors:  Kenji Kumagai; Katsuaki Motomura; Masayuki Egashira; Masato Tomita; Masahiko Suzuki; Masataka Uetani; Hiroyuki Shindo
Journal:  Skeletal Radiol       Date:  2008-06       Impact factor: 2.199

8.  Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.

Authors:  N S Adegbite; M Xu; F S Kaplan; E M Shore; R J Pignolo
Journal:  Am J Med Genet A       Date:  2008-07-15       Impact factor: 2.802

9.  Progressive osseous heteroplasia in a 10-year-old male child.

Authors:  Girish K Singh; Vikas Verma
Journal:  Indian J Orthop       Date:  2011-05       Impact factor: 1.251

Review 10.  Fibrodysplasia ossificans progressiva: clinical and genetic aspects.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Orphanet J Rare Dis       Date:  2011-12-01       Impact factor: 4.123

View more
  1 in total

1.  Progressive osseous heteroplasia: a case report and literature review.

Authors:  Keyun Zhang; Hairong Tang; Renming Zhang; Yongchao Wang; Qin Su; Xin Lin; Qiang Tian; Sheng Cao; Meichun Fu; Jian Zhu; Xiaoqing Shen; Feng Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.